Tag: SwRI

UTSA-Led Collaborative Team Wins Grant to Develop a COVID-19 Vaccine
Articles, Featured

UTSA-Led Collaborative Team Wins Grant to Develop a COVID-19 Vaccine

A consortium of scientists from San Antonio's four largest research institutions won a $200,000 grant to fund COVID-19 vaccine development. Dr. Karl Klose, director of the South Texas Center for Emerging Infectious Diseases and professor of microbiology at The University of Texas at San Antonio (UTSA), leads the team. The presidents of UTSA, UT Health San Antonio, Southwest Research Institute (SwRI), and the Texas Biomedical Research Institute (Texas Biomed) formed a new nonprofit in October 2019 called the San Antonio Partnership for Precision Therapeutics or SAPPT. The partnership funds researchers from the four institutions who work together on the interdisciplinary development of breakthrough therapies customized for patients. Soon after the City of San Antonio announced pandemic res...
New Precision Therapeutics Partnership to Highlight San Antonio’s Unique Bioscience Capabilities
Articles, Featured

New Precision Therapeutics Partnership to Highlight San Antonio’s Unique Bioscience Capabilities

Tuesday's announcement of a new major collaborative initiative focused on San Antonio's unique strengths in precision therapeutics will help boost the city's biomedical capability for innovation in healthcare. The presidents of San Antonio’s four largest research institutions announced Tuesday they are collectively funding the new nonprofit San Antonio Partnership for Precision Therapeutics or SAPPT with $800,000 from UT Health San Antonio, the Texas Biomedical Research Institute (Texas Biomed), The University of Texas at San Antonio (UTSA), and Southwest Research Institute (SwRI). This groundbreaking initiative will fund researchers working collaboratively across the four institutions, serving as a model for interdisciplinary development of breakthrough therapies customized for each pa...
GaitIQ Spots Early Signs of Alzheimer’s in Your Walk
Articles, Featured

GaitIQ Spots Early Signs of Alzheimer’s in Your Walk

Can technology help predict your risk for Alzheimer’s disease years or decades before symptoms of dementia appear? One San Antonio team is working to do just that using deep learning and artificial intelligence (AI) to analyze a video taken in your doctor’s office.Rick Morris is the San Antonio-based entrepreneur who founded GaitIQ, an early-stage digital health Software as a Service (SaaS) company in 2017. The GaitIQ cloud-based platform will give healthcare providers an affordable, easy-to-use application to measure a patient’s gait. The technology leverages machine vision, AI, and big data analytics to evaluate subtle changes in the way a person walks that have been linked to the risk for dementia.Changes in gait are important early warning sign of cognitive decline and emerge a...
San Antonio Hub To Foster Pediatric Medical Device Development
Articles, Featured

San Antonio Hub To Foster Pediatric Medical Device Development

The San Antonio-Austin hub of a pediatric medical device consortium announced Monday it is actively looking for innovative pediatric medical device entrepreneurs in need of investment and development resources.The Southwest National Pediatric Device Consortium (SWPDC) recently received a U.S. Food & Drug Administration (FDA) five-year grant for $6.75 million. Texas Children’s Hospital (TCH), the largest children’s hospital in the U.S., and Baylor College of Medicine (BCM), one of the largest recipients for pediatric federal research funding in the U.S. anchor the consortium. The FDA grant went into effect Sept. 1. and will enable the consortium to support pediatric medical device innovators with product, technology, and business acceleration services both regionally and nationally....
SwRI Shares Pharmaceutical Expertise with New Workshop Oct. 8
Articles, Featured

SwRI Shares Pharmaceutical Expertise with New Workshop Oct. 8

Southwest Research Institute (SwRI) is hosting a one-day workshop on Oct. 8 to teach life science professionals strategies and tools needed for a more successful investigational new drug (IND) submission. This workshop, to be held at SwRI, is designed for beginner- to intermediate-level bioscience professionals involved in new drug development.The workshop will help showcase SwRI’s specialized capabilities such as its new clean room, high-potency laboratory space, and complimentary storage facility to the bioscience community. The institute’s 2017 annual report details recent infrastructure investments and educational outreach efforts such as this inaugural workshop that can help attract more drug development to SwRI as well as benefit local startups bringing drugs to market.The Sm...